Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 1 Hershey Dr SMITHS FALLS ON K7A 0A8 |
Tel: | N/A |
Website: | https://www.canopygrowth.com |
IR: | See website |
Key People | ||
David Eric Klein Chief Executive Officer, Director | Judy Hong Chief Financial Officer | Christelle Gedeon Chief Legal Officer and Company Secretary |
Business Overview |
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products. |
Financial Overview |
For the six months ended 30 September 2024, Canopy Growth Corp revenues decreased 11% to C$129.2M. Net loss before extraordinary items increased 64% to C$260.7M. Revenues reflect This Works segment decrease from C$13.1M to C$0K, Other segment decrease from C$6M to C$0K, Canada segment decrease of 34% to C$74.8M, Others segment decrease of 63% to C$8.8M. |
Employees: | 1,029 as of Mar 31, 2024 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $1,104M as of Sep 30, 2024 |
Annual revenue (TTM): | $280.50M as of Sep 30, 2024 |
EBITDA (TTM): | -$51.99M as of Sep 30, 2024 |
Net annual income (TTM): | -$585.69M as of Sep 30, 2024 |
Free cash flow (TTM): | -$167.34M as of Sep 30, 2024 |
Net Debt Last Fiscal Year: | $382.30M as of Sep 30, 2024 |
Shares outstanding: | 105,360,224 as of Nov 13, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |